Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1995 | 1 |
1996 | 1 |
1997 | 1 |
2000 | 1 |
2011 | 1 |
2015 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
RET activation by germline MEN2A and MEN2B mutations.
Oncogene. 1995 Dec 7;11(11):2419-27.
Oncogene. 1995.
PMID: 8570194
A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations.
Iwashita T, Murakami H, Kurokawa K, Kawai K, Miyauchi A, Futami H, Qiao S, Ichihara M, Takahashi M.
Iwashita T, et al.
Biochem Biophys Res Commun. 2000 Feb 24;268(3):804-8. doi: 10.1006/bbrc.2000.2227.
Biochem Biophys Res Commun. 2000.
PMID: 10679286
Item in Clipboard
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer.
Cosci B, Vivaldi A, Romei C, Gemignani F, Landi S, Ciampi R, Tacito A, Molinaro E, Agate L, Bottici V, Cappagli V, Viola D, Piaggi P, Vitti P, Pinchera A, Elisei R.
Cosci B, et al.
Endocr Relat Cancer. 2011 Sep 20;18(5):603-12. doi: 10.1530/ERC-11-0117. Print 2011 Oct.
Endocr Relat Cancer. 2011.
PMID: 21810974
Item in Clipboard
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.
Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjöld M, Komminoth P, Hendy GN, Mulligan LM, et al.
Eng C, et al.
JAMA. 1996 Nov 20;276(19):1575-9.
JAMA. 1996.
PMID: 8918855
Item in Clipboard
Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain.
Pasini A, Geneste O, Legrand P, Schlumberger M, Rossel M, Fournier L, Rudkin BB, Schuffenecker I, Lenoir GM, Billaud M.
Pasini A, et al.
Oncogene. 1997 Jul 24;15(4):393-402. doi: 10.1038/sj.onc.1201199.
Oncogene. 1997.
PMID: 9242375
Item in Clipboard
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Mandelker D, Zhang L, Kemel Y, Stadler ZK, Joseph V, Zehir A, Pradhan N, Arnold A, Walsh MF, Li Y, Balakrishnan AR, Syed A, Prasad M, Nafa K, Carlo MI, Cadoo KA, Sheehan M, Fleischut MH, Salo-Mullen E, Trottier M, Lipkin SM, Lincoln A, Mukherjee S, Ravichandran V, Cambria R, Galle J, Abida W, Arcila ME, Benayed R, Shah R, Yu K, Bajorin DF, Coleman JA, Leach SD, Lowery MA, Garcia-Aguilar J, Kantoff PW, Sawyers CL, Dickler MN, Saltz L, Motzer RJ, O'Reilly EM, Scher HI, Baselga J, Klimstra DS, Solit DB, Hyman DM, Berger MF, Ladanyi M, Robson ME, Offit K.
Mandelker D, et al.
JAMA. 2017 Sep 5;318(9):825-835. doi: 10.1001/jama.2017.11137.
JAMA. 2017.
PMID: 28873162
Free PMC article.
Item in Clipboard
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.
Richards S, et al.
Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.
Genet Med. 2015.
PMID: 25741868
Free PMC article.
Item in Clipboard
Cite
Cite